Fate Therapeutics
FATE
FATE
146 hedge funds and large institutions have $71M invested in Fate Therapeutics in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 54 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $102M → $71M (-$30.6M)
43% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 54
43% less call options, than puts
Call options by funds: $70K | Put options by funds: $122K
Holders
146
Holding in Top 10
1
Calls
$70K
Puts
$122K
Top Buyers
| 1 | +$1.83M | |
| 2 | +$1.32M | |
| 3 | +$1M | |
| 4 |
Two Sigma Advisers
New York
|
+$774K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$660K |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$1.03M | |
| 3 | -$949K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$841K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$621K |
